Ripretinib

Overview

Ripretinib is an orally bioavailable KIT/PDGFR inhibitor with antitumor effect. It binds to both wild-type and mutant forms of KIT and PDGFRa at their switch pocket binding site.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | PDGFR

Product Information

• Catalog No.: B2693-291572
• CAS No.: 1442472-39-0
• Molecular Formula: C24H21BrFN5O2
• Molecular Weight: 510.36

Source

Original product source